Get started
Author

Monica Borgonovi

Observed names: Borgonovi, Monica, M Borgonovi, M. Borgonovi, MONICA BORGONOVI
Institution: Galapagos (France)
ORCID: 0000-0002-2351-3226
Observed ORCID: 0000-0002-2351-3226
OpenAlex ID: A5087066192
In-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic
1999 · Gianpaolo Candiani, Monica Abbondi, et al. · Journal of Antimicrobial Chemotherapy · 150
Activities of Ceftazidime and Avibactam against β-Lactamase-Producing Enterobacteriaceae in a Hollow-Fiber Pharmacodynamic Model
2014 · Ken Coleman, Premavathy Levasseur, et al. · Antimicrobial Agents and Chemotherapy · 90
PDF
Discovery ofN-(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-lH-pyrazole-5-carboxamide (GLPG1837), a Novel Potentiator Which Can Open Class III Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels to a High Extent
2017 · Steven E. Van der Plas, Hans Kelgtermans, et al. · Journal of Medicinal Chemistry · 65
Teicoplanin metabolism in humans
1992 · A Bernareggi, A Borghi, et al. · Antimicrobial Agents and Chemotherapy · 54
Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary Fibrosis
2021 · Oscar Mammoliti, Adeline Palisse, et al. · Journal of Medicinal Chemistry · 34
Evaluation of a novel CFTR potentiator in COPD ferrets with acquired CFTR dysfunction
2021 · Niroop Kaza, Vivian Y. Lin, et al. · European Respiratory Journal · 29
PDF
Mulundocandin, an Echinocandin-like Lipopeptide Antifungal Agent: Biological Activities In Vitro.
1999 · STEPHEN HAWSER, MONICA BORGONOVI, et al. · The Journal of Antibiotics · 29
PDF
Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases
2024 · Christophe Peixoto, Agnes Joncour, et al. · Journal of Medicinal Chemistry · 28
Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312
2023 · Taouès Temal-Laib, Christophe Peixoto, et al. · Journal of Medicinal Chemistry · 24
PDF
Discovery and Optimization of Orally Bioavailable Phthalazone and Cinnolone Carboxylic Acid Derivatives as S1P2 Antagonists against Fibrotic Diseases
2021 · Oscar Mammoliti, Koen Jansen, et al. · Journal of Medicinal Chemistry · 22
Discovery of GLPG3667, a Selective ATP Competitive Tyrosine Kinase 2 Inhibitor for the Treatment of Autoimmune Diseases
2024 · Oscar Mammoliti, Sébastien Martina, et al. · Journal of Medicinal Chemistry · 19
The effect of aminocandin (HMR 3270) on the in-vitro adherence of Candida albicans to polystyrene surfaces coated with extracellular matrix proteins or fibronectin
2006 · E. Cateau, P. Levasseur, et al. · Clinical Microbiology and Infection · 17
Teicoplanin binding in plasma following administration of increasing intravenous doses to healthy volunteers.
1991 · A Bernareggi, M Borgonovi, et al. · PubMed · 15
Experimental lobar pneumonia due to penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae in immunocompetent and neutropenic rats: efficacy of penicillin and teicoplanin treatment
1997 · G. Candiani, M. Abbondi, et al. · Journal of Antimicrobial Chemotherapy · 14
Discovery of GLPG2737, a Potent Type 2 Corrector of CFTR for the Treatment of Cystic Fibrosis in Combination with a Potentiator and a Type 1 Co-corrector
2024 · Mathieu Pizzonero, Rhalid Akkari, et al. · Journal of Medicinal Chemistry · 13
Antimicrobial activity of MDL 62,873, a semisynthetic derivative of teicoplanin, in vitro and in experimental infections
1992 · M Berti, G Candiani, et al. · Antimicrobial Agents and Chemotherapy · 11
ADAMTS-5 inhibition with the potent and highly selective inhibitor GLPG1972 results in strong disease-modifying OA drug effects in the rat meniscectomy model
2018 · P. Clement-Lacroix, S. Meurisse, et al. · Osteoarthritis and Cartilage · 7
PDF
P794 The efficacy of ceftazidime combined with NXL104, a novel β-lactamase inhibitor, in a mouse model of kidney infections induced by β-lactamase producing Enterobacteriaceae
2007 · M. Borgonovi, C. Miossec, et al. · International Journal of Antimicrobial Agents · 6
Plasma and tonsillar tissue pharmacokinetics of teicoplanin following intramuscular administration to children
1998 · Leon Aarons, Malcolm Rowland, et al. · European Journal of Pharmaceutical Sciences · 6
Pharmacokinetics of MDL 63,246, a new semisynthetic glycopeptide antibiotic, in the rat
1995 · M Borgonovi, L A Cavenaghi, et al. · Antimicrobial Agents and Chemotherapy · 6
Design of a potent and selective dual JAK1/TYK2 inhibitor
2024 · Oscar Mammoliti, Christel Menet, et al. · Bioorganic & Medicinal Chemistry · 5
OP0161 The JAK1 selective inhibitor filgotinib regulates both enthesis and colon inflammation in a mouse model of psoriatic arthritis
2017 · C Robin-Jagerschmidt, S Lavazais, et al. · Annals of the Rheumatic Diseases · 5
PDF
Pos0442 Glpg4399: Selective Sik3 Inhibition as a Novel Mode of Action for the Treatment of Inflammatory Arthritic Diseases (preclinical)
2022 · S. Lavazais, A. Pereira-Fernandes, et al. · Annals of the Rheumatic Diseases · 4
PDF
OP0258 Efficacy of the highly selective adamts-5 inhibitor glpg1972 in the rat meniscectomy model
2018 · L. Lepescheux, P. Clement-Lacroix, et al. · Annals of the Rheumatic Diseases · 4
PDF
HBsAg Suppression by a New Series of HBV RNA Destabilizers: Discovery and Effects on In Vitro Neurite Outgrowth
2026 · Jacques Huck, Caroline Joannesse, et al. · Journal of Medicinal Chemistry · 3
Works count: 34
Citation count: 666
H-index: 14
I10-index: 16
Year
Topic
Type